Sign in
4

Changes in Ownership

Enveric Biosciences, Inc. Filed Acc 0001209191-05-065862

Chairman/CEO/CFO/Secretary acquired 11,304 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MANDELL HENRY R Chairman/CEO/CFO/Secretary 2005-12-29 Conversion +11,304 $0.56 $6,330 662,876 D
Derivatives
MANDELL HENRY R Chairman/CEO/CFO/Secretary 2005-12-29 Conversion · Series B-1 Redeemable Convertible Preferred Stock −633 0 D
Loading xslF345X02/bla15831_bla1hrm.xml…